Table 3 Prediction of 12-month mortality in ICU patients that were discharged from ICU after >3 days of iv glutamine supplementation
From: Plasma glutamine concentration after intensive care unit discharge: an observational study
a. Univariate logistic regression analysis in group A, patients sampled at discharge and longitudinally post ICU (n = 63) | ||||
|---|---|---|---|---|
OR (95% CI) | P | |||
Discharge SOFA (per point) | 1.38 (1.14-1.67) | 0.0003 | ||
Dialysis at discharge | 9.49 (2.25-39.9) | 0.0008 | ||
Discharge P-glutamine (per μmol/L) | 1.004 (1.001-1.007) | 0.0046 | ||
Admission SAPS III (per point) | 1.041 (1.002-1.081) | 0.033 | ||
Discharge total amino acids (per μmol/L) | 1.0008 (1.0000-1.0016) | 0.042 | ||
b. Stepwise multiple logistic regression analysis in group A, patients sampled at discharge and longitudinally post ICU (n = 63) | ||||
β | OR (95% CI) | P | % Correct | |
Intercept | −5.45 | 0.004 (0.0002-0.081) | ||
Discharge SOFA (per point) | 0.335 | 1.40 (1.13-1.72) | 0.0004 | 73.0 |
Discharge P-glutamine (per μmol/L) | 0.041 | 1.004 (1.001-1.008) | 0.0043 | 76.2 |
c. Univariate logistic regression analysis in group B, patients sampled 24–72 hours post ICU (n = 92) | ||||
OR (95% CI) | P | |||
Discharge SOFA (per point) | 1.17 (1.02-1.34) | 0.025 | ||
Post ICU P-glutamine (per μmol/L) | 1.0008 (0.9985-1.0031) | 0.49 | ||
Admission SAPS III (per point) | 1.06 (1.02-1.09) | 0.0007 | ||